Comparison of three oxytetracycline regimens for the treatment of persistent Anaplasma marginale infections in beef cattle

Veterinary Parasitology

Volumn 127, Issue 1, 2005, Pages 61-73

  Coetzee, Johann F ^a   Apley, Michael D ^a   Kocan, Katherine M ^b   Rurangirwa, Fred R ^c   Van Donkersgoed, Joyce ^d  

^a IOWA STATE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Alberta Cattle Feeders' Association   (Canada)

Author keywords

Anaplasma marginale; Oxytetracycline; Persistent infections; Therapy

Indexed keywords

ANTIBIOTIC AGENT; OXYTETRACYCLINE; TETRADURE; ANTIPROTOZOAL AGENT; PROTOZOAL DNA; PROTOZOON ANTIBODY;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL VIRULENCE; BODY WEIGHT; CATTLE DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; INOCULATION; NONHUMAN; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; RANDOMIZATION; SPLENECTOMY; TREATMENT FAILURE; ANIMAL; ANIMAL DISEASE; BLOOD; CATTLE; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ERYTHROCYTE; GENETICS; HEMATOCRIT; HETEROZYGOTE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIVARIATE ANALYSIS; PARASITEMIA; PARASITOLOGY; RANDOMIZED CONTROLLED TRIAL;

ACARI; ANAPLASMA; ANAPLASMA MARGINALE; ANIMALIA; BOS TAURUS; RICKETTSIA;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIPROTOZOAL AGENTS; CARRIER STATE; CATTLE; CATTLE DISEASES; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; HEMATOCRIT; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; MULTIVARIATE ANALYSIS; OXYTETRACYCLINE; PARASITEMIA; POLYMERASE CHAIN REACTION;

EID: 11144351704     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2004.08.017     Document Type: Article

References (40)

1. F.J. Alderink, and R.A. Dietrick Economic and epidemiological implications of anaplasmosis in Texas cattle herds Proceedings of the 86th Annual Meeting of the United States Animal Health Association 1982 66 75
2. E.F. Blouin, A.F. Barbet, Y. Jooyoung, K.M. Kocan, and J.T. Saliki Establishment and characterization of an Oklahoma isolate of Anaplasma marginale in cultured Ixodes scapularis cells Vet. Parasitol. 87 4 2000 301 313
3. E.F. Blouin, K.M. Kocan, J. de la Fuente, and J.T. Saliki Effect of tetracycline on development of Anaplasma marginale in cultured Ixodes scapularis cells Vet. Parasitol. 107 2002 115 126
4. Canadian Food Inspection Agency Web Site, 2002. Restricted feeder cattle from the United States. Animal Products Animal Health and Production Division. Document No. APHD-DSAE-IE-2001-14-2, August 6, 2002, accessed on 28 July 2003. http://www.inspection.gc.ca/english/anima/heasan/policy/ie-2001-14-2e.shtml.
5. C.R. Clark, and P.M. Dowling Pharmacokinetic comparison of two long-acting oxytetracycline formulations in cattle Proceedings of the 20th Annual ACVIM Forum 2003 773
6. J.S. Dumler, A.F. Barbet, C.P.J. Bekker, J.S. Dasch, G.H. Palmer, S.C. Ray, Y. Rikihisa, and F.R. Rurangirwa Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichiawith Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila Int. J. Syst. Evol. Microbiol. 51 2001 2145 2165
7. W.P. Eckblad, S.D. Lincoln, and R.A. Magonigle Efficacy of terramycin/LA-200 administered during the prepatent period of anaplasmosis Proc. Annu. Meet. US Anim. Health Assoc. 83 1979 44 52
8. I.S. Eriks, G.H. Palmer, T.C. McGuire, D.R. Allred, and A.F. Barbet Detection and quantitation of Anaplasma marginale in carrier cattle by using a nucleic acid probe J. Clin. Microbiol. 27 2 1989 279 284
9. B.S. Everitt The analysis of repeated measures: a practical review with examples Statistician 44 1 1995 113 135
10. B.S. Everitt, and G. Dunn Applied Multivariate Data Analysis 2001 Arnold London 223 pp
11. Food and Drug Administration (FDA) Web Site, 2003. Searched for Anaplasmosis and Veterinary, accessed on December 2, 2003. http://google.fda. gov/search?restrict=veterinary&q=anaplasmosis.
12. J.E. Futse, M.W. Ueti, D.P. Knowles, and G.H. Palmer Transmission of Anaplasma marginale by Boophilus microplus: retention of vector competence in the absence of vector-pathogen interaction J. Clin. Microbiol. 41 2003 3829 3834
13. W.L. Goff, D. Stiller, R.A. Roeder, L.W. Johnson, D. Falk, J.R. Gorham, and T.C. McGuire Comparison of a DNA probe, complement-fixation and indirect immunofluorescence tests for diagnosing Anaplasma marginale in suspected carrier cattle Vet. Microbiol. 24 1996 381 390
14. W.J. Goodger, T. Carpenter, and H. Riemann Estimation of economic loss associated with Anaplasmosis in California beef cattle J. Am. Vet. Med. Assoc. 174 12 1979 1333 1336
15. K.M. Kocan, J. de la Fuente, A.A. Guglielmone, and R.D. Melendez Antigens and alternatives for control of Anaplasma marginale infection in cattle Clin. Microbiol. Rev. 2003 698 712
16. K.L. Kuttler, and J.E. Simpson Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomised calves Am. J. Vet. Res. 39 2 1978 347 349
17. K.L. Kuttler Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis J. Am. Vet. Med. Assoc. 176 10 1980 1103 1108
18. K.L. Kuttler, L.W. Johnson, and J.E. Simpson Chemotherapy to eliminate Anaplasma marginale under field and laboratory conditions Proceedings of the 84th Annual Meeting of the US Animal Health Association 1980 73 82
19. K.L. Kuttler Influence of a second Anaplasmaexposure on the success of the treatment to eliminate Anaplasma carrier infections in cattle Am. J. Vet. Res. 44 5 1983 882 883
20. M.F. Landoni, and J.O. Errecalde Tissue concentrations of a long-acting oxytetracycline formulation after intramuscular administration in cattle Rev. Sci. Technol. 11 3 1992 909 915
21. S.D. Lincoln, W.P. Eckblad, and R.A. Magonigle Bovine Anaplasmosis: clinical, haematological, and serological manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period Am. J. Vet. Res. 43 8 1982 1360 1362
22. R.A. Magonigle, H.W. Renshaw, H.W. Vaughn, E.H. Stauber, and F.W. Frank Effect of five daily treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis J. Am. Vet. Med. Assoc. 167 12 1975 1080 1083
23. R.A. Magonigle, and T.J. Newby Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injection Am. J. Vet. Res. 43 12 1982 2170 2172
24. OIE (Office International des Epizooties Web Site), 2003. Terrestrial Animal Health Code. Bovine Anaplasmosis, Chapter 2.3.7, accessed on July 28. http://www.oie.int/eng/normes/mcode/a_00062.htm.
25. OIE (Office International des Epizooties Web Site), 2000. Manual of Standards for Diagnostic Tests and Vaccines, fourth ed., Chapter 2.3.7, accessed on December 3. http://www.oie.int/eng/normes/mmanual/a_00054.htm.
26. M.B. Ozlem, Z. Karaer, K. Turgut, H. Eren, K. Irmak, and A. Inci Efficacy of long-acting oxytetracycline on bovine anaplasmosis A. U Vet. Fak. Derg. 35 1 1988
27. D.C. Plumb Veterinary Drug Handbook 2002 Iowa State Press Ames 643 pp.
28. Potgieter, F.T., Stoltsz, W.H., 1994. Anaplasmosis. In: Coetzer, J.A.W., Thompson, G.R., Tustin, R.C. (Eds.), Infectious Diseases of Livestock - With Special Reference to Southern Africa. Oxford University Press, Cape Town, pp. 408-430.
29. F.L. Ramsey, and D.W. Schafer The Statistical Sleuth 2nd ed. 2002 Duxbury Pacific Grove, CA 552 pp.
30. J.D. Reeves, and B.L. Swift Iatrogenic transmission of Anaplasma marginale in beef cattle Vet. Med./Small Anim. Clin. 72 5 1977 911 912
31. T.O. Roby, J.E. Simpson, and T.E. Amerault Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline Am. J. Vet. Res. 39 7 1978 1115 1116
32. R.J. Rogers, and P.J. Dunster The elimination of Anaplasma marginale from carrier cattle by treatment with long acting oxytetracycline Aust. Vet. J. 61 9 1984 306
33. E.M. Scholar, and W.B. Pratt Bacteriostatic inhibitors of protein synthesis: tetracyclines The Antimicrobial Drugs second ed. 2000 Oxford University Press New York pp. 184-199
34. Smith, B.P. (Ed.), 1996. Large Animal Internal Medicine, second ed. Mosby, St. Louis, 2040 pp.
35. C.G. Stewart, A. Immelman, P. Grimbeek, and D. Grib The use of a short and long acting oxytetracycline for the treatment of Anaplasma marginalein splenectomized calves J. S. Afr. Vet. Assoc. 50 1979 83 85
36. B.L. Swift, and G.M. Thomas Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline J. Am. Vet. Med. Assoc. 183 1 1983 63 65
37. J.R. Thompson, K.W. Kersting, W.M. Wass, I.A. Davis, and K.H. Plumlee Splenectomy in cattle via transthoracic approach Am. J. Vet. Res. 53 1 1992 143 144
38. S. Torioni De Echaide, D.P. Knowles, T.C. McGuire, G.H. Palmer, C.E. Suarez, and T.F. MeElwain Detection of cattle naturally infected with Anaplasma marginale by nested PCR and a competitive enzyme-linked immunosorbent assay using recombinant Major Surface Protein 5 J. Clin. Microbiol. 36 3 1998 777 782
39. G. Uilenberg International collaborative research: significance of tick-borne hemoparasitic diseases to world animal health Vet. Parasitol. 57 1995 19 41
40. VMRD, 2003. Anaplasma Antibody Test Kit, cELISA, accessed on December 3, 2003. http://www.vmrd.com/docs/tk/Anaplasma%202-plate%20circular%20021202.pdf.